N-acetylcysteine: Effective in bipolar depression?

N-acetylcysteine (NAC) is a derivative of the naturally occurring amino-acid cysteine. Many people use it as a nutritional supplement, but NAC also has clear pharmacological properties. By far the most important role of NAC is as an ‘antidote’ in cases of paracetamol overdose. In this role, it can be life-saving.

However, the properties of NAC may extend beyond the emergency room. Recent research from Australia suggests it might be effective in the depressive phase of bipolar disorder. http://www.scielo.br/pdf/rbp/v33n4/v33n4a11.pdf

Larger studies are needed, but if the initial promise holds true, this would represent an important advance. In bipolar disorder, the depressive phase can be extremely difficult to shift, although conventional pharmacology has also made some significant inroads in the past few years. http://journals.psychiatryonline.org/data/Journals/AJP/4013/1351.pdf

 

Major Depression: What is currently known?

“About one in five people will suffer from major depression at some point in their lives. Aside from the psychological burden, people suffering from depression are known to be at higher risk of heart disease”.

But what are the causes of depression? What happens in the brain when someone is depressed? And which treatments work best?

Writing in the Lancet, Phillips and colleagues from the University of Pittsburgh give an authoritative account of the current state of the art. They appraise the evidence for antidepressant drugs and psychological therapies, and highlight promising new treatment strategies.

Kupfer DJ, Frank E & Phillips ML (2012) Major depressive disorder: new clinical, neurobiological and treatment perspectives. Lancet 379:1045-55.

The full article is available at:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397431/

Cannabis and schizophrenia

Recently Dr Paul Morrison was quoted in an article by Patrick Cockburn in ‘The Independent’ on Cannabis and its relationship to mental health problems.

“Cannabis consumption has been falling in Britain as well as the rest of northern Europe since 2004, but the age when teenagers start taking the drug is also going down. There has been a nearly 20-fold increase in first-time use by under-18s, with 40 per cent of under 15-year-olds in the UK having used the drug. This is a dangerous trend. Dr Morrison says “adolescence seems to be the critical variable when the neural-circuits are being sculpted and the personality is emerging”.

To read the article in full please use this link:
http://www.independent.co.uk/life-style/health-and-families/health-news/is-this-the-tobacco-moment-for-cannabis-8349054.html